December 29, 2016 / 1:41 PM / 10 months ago

BRIEF-Aptose Biosciences provides update on APTO-253 development

Dec 29 (Reuters) - Aptose Biosciences Inc :

* Aptose Biosciences provides update on apto-253 development

* Aptose Biosciences Inc - has successfully manufactured multiple batches of a new drug product formulation for APTO-253

* Aptose Biosciences - will have to repeat production of fourth batch, a 40l batch that was intended clinical supply

* Aptose Biosciences - will have to repeat production of fourth batch because of a correctable engineering design incompatibility during filling process

* Aptose - “while we have encountered delays in manufacturing activities, we also have continued mechanistic and pharmacokinetic testing of APTO-253”

* Aptose Biosciences Inc - also continue to advance development of CG‘806

* Aptose -expects batch records,release specifications from such new batch, alongwith stability,sterility data,be provided to FDA during q1 2017

* Aptose Biosciences provides update on apto-253 development Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below